datamap.de

What It Is

DATAMAP GmbH is a clinical research organization (CRO) based in Freiburg, Germany. Founded in 1992, it focuses on data management, clinical programming, biostatistics, statistical consulting, and data presentation for clinical research. It is worth noting that, based on the content on its official website, it is not a typical self-service SaaS platform that users can register for and purchase directly, but rather a professional services provider for pharmaceutical companies, clinical research organizations, biotechnology firms, and medical device clients.

Core Capabilities

DATAMAP’s core service areas include clinical data management, clinical programming, biostatistical analysis, and statistical consulting. The website highlights that it has supported more than 1,300 studies, trials, and other projects across therapeutic areas such as cardiovascular disease, COVID-19, diabetes, gastroenterology, infectious diseases, oncology, respiratory diseases, vaccines, and medical devices. In terms of delivery, DATAMAP can use its own internal IT infrastructure or access client systems directly via VPN, indicating that it can adapt to clients’ existing clinical research environments.

Pricing and Business Model

The official website does not disclose packages, subscription pricing, a free plan, or trial information. Given its positioning as a CRO, its services are most likely quoted on a custom basis according to project scope, study complexity, required input for data management/statistics/programming, and compliance requirements, rather than being priced like a standard seat-based SaaS product.

Pros and Cons

Its strengths lie in more than 30 years of deep experience in the clinical data field, with a team that includes data managers, clinical programmers, statisticians, quality management personnel, and business IT staff. Its quality system appears relatively comprehensive, covering SOPs, quality control, internal audits, external audits, and continuous training, while explicitly following requirements such as ICH, GCP, GAMP5, and GDPR. The drawback is that the website provides limited information about productized software capabilities—for example, interfaces, workflows, permissions, APIs, third-party integrations, deployment architecture, and payment methods are not sufficiently disclosed. As a result, it is not well suited to being evaluated as a general-purpose SaaS tool.

Who It’s For

DATAMAP is suitable for pharmaceutical, biotechnology, and medical device companies that need to outsource clinical trial data management, biostatistics, clinical programming, and compliant delivery—especially European or global clinical research project teams that value flexible communication, quality control, and long-term collaboration.

Access from China

The website does not provide information about access from China, ICP filing, Chinese-language support, or China-based nodes, so actual connectivity is unknown. If Chinese clients use its services, the more important issues will be cross-border data compliance, VPN access, coordination between GDPR and local regulations, and related requirements, all of which should be confirmed separately before procurement.